
About Vesuvius Pharma Private Limited
Data last updated:
Vesuvius Pharma Private Limited is a private limited company based in Pune, Maharashtra, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 26 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U33119PN2019PTC183766. Its GSTIN is 27AAGCV9134M1ZP (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sagar Dilip Shinde (Managing Director) and Trupti Sagar Shinde.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sr No 146/A/2 Renuka House Office No 2 1st Floor Parvati Gaon Pune, Maharashtra, India – 411009.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.69 Lakh, a growth of 76% compared to the previous year. For the same year it recorded a net profit of ₹1.03 Lakh (net margin 2.9%) and EBITDA of ₹2.11 Lakh (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 91% over three years and 102% over five years.
For more details, the company can be reached via its website vesuviusinc.com.
Company details
Recognitions & Rankings of Vesuvius Pharma
Contact details
Vesuvius Pharma Private Limited's registered office is in Pune, Maharashtra. Its website is vesuviusinc.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressSr No 146/A/2 Renuka House Office No 2 1st Floor Parvati Gaon Pune, Maharashtra, India – 411009
- IndustryHealthcare, Manufacturing, Other Medical And Surgical Equipment, Medical & Surgical Equipment, Orthopedic Appliances, Medical Appliances And Instruments
To see the full contact details of Vesuvius Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vesuvius Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Vesuvius Pharma Private Limited, buy the company report.
Financials of Vesuvius Pharma Private Limited
FY 2025 filings availableVesuvius Pharma Private Limited reported revenue of ₹35.69 Lakh (up 76% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 102% over five years, including 76% growth in the latest year. EBITDA rose 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vesuvius Pharma Private Limited, buy the company report.
Board of directors of Vesuvius Pharma Private Limited
Vesuvius Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Trupti Sagar Shinde | Director | 24 Jul 2019 | 7 Years 3 Months | Current |
| Sagar Dilip Shinde | Managing Director | 26 Apr 2019 | 7 Years 5 Months | Current |
Peer comparison
Vesuvius Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hothaat Marketplace Private Limited | ₹35.71 Lakh (FY 2019) | -58.0% | Indore, Madhya Pradesh, India | |||
| Pawansathi Homes Private Limited | ₹35.71 Lakh (FY 2025) | -61.0% | Kolkata, West Bengal, India | |||
| Ozone Multi Services Private Limited | ₹35.71 Lakh (FY 2018) | -23.0% | Bathinda, Punjab, India | |||
| Novique Health Private Limited | ₹35.7 Lakh (FY 2022) | -33.0% | Pune, Maharashtra, India | |||
| Top Class Logistics Private Limited | ₹35.7 Lakh (FY 2025) | -7.0% | Kolkata, West Bengal, India | |||
| Vesuvius Pharma Private Limitedthis company | ₹35.69 Lakh (FY 2025) | ₹1.03 Lakh | 2.9% | 76.0% | Pune, Maharashtra, India | |
| Medx Network Private Limited | ₹35.69 Lakh (FY 2024) | -1.0% | Raipur, Chhattisgarh, India | |||
| KLHL Enterprises Private Limited | ₹35.69 Lakh (FY 2024) | -9.0% | Kolkata, West Bengal, India | |||
| Achyut Stationery Private Limited | ₹35.69 Lakh (FY 2019) | New Delhi, Delhi, India | ||||
| Padmatheertham Ventures Private Limited | ₹35.68 Lakh (FY 2024) | -69.0% | Thiruvananthapuram, Kerala, India | |||
| Snug Fire Fighting Solutions Private Limited | ₹35.68 Lakh (FY 2020) | 43.0% | Thodupuzha, Kerala, India |
To see the full peer comparison of Vesuvius Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vesuvius Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vesuvius Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vesuvius Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCV9134M1ZP | Maharashtra | Active | 11 Jun 2019 |
To see the full GST registrations and return filing status of Vesuvius Pharma Private Limited, buy the company report.
Recent activity
Vesuvius Pharma Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Trupti Sagar Shinde ceased to be Additional Director on 31 Dec 2020.
Frequently asked questions
Vesuvius Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 26 April 2019 (7+ years old) and is registered under CIN U33119PN2019PTC183766.
Vesuvius Pharma has 2 current directors:
- Sagar Dilip Shinde - Managing Director
- Trupti Sagar Shinde - Director
The latest financial statements of Vesuvius Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Vesuvius Pharma is 27AAGCV9134M1ZP, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vesuvius Pharma is U33119PN2019PTC183766. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vesuvius Pharma was incorporated on 26 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Vesuvius Pharma by revenue are Hothaat Marketplace Private Limited, Pawansathi Homes Private Limited, Ozone Multi Services Private Limited, Novique Health Private Limited, Top Class Logistics Private Limited and 5 more, all in the same principal business activity (retail trading).
Trupti Sagar Shinde ceased to be Additional Director on 31 Dec 2020. Sagar Dilip Shinde ceased to be Director on 27 Jun 2020. Trupti Sagar Shinde was appointed as Director on 24 Jul 2019. Vesuvius Pharma has 4 board changes on record in total.
Yes, Vesuvius Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Vesuvius Pharma can be reached through the website vesuviusinc.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Vesuvius Pharma is at Sr No 146A2 Renuka House Office No 2 1st Floor Parvati Gaon Pune, Maharashtra, India – 411009.